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Abstract
In the fields of psychiatry and neurology, the dopaminergic system is one of the most im-
portant neurotransmitter systems in the brain. Whereas pharmacological and biochemical studies
had initially indicated two subclasses of dopamine receptors (DA-R), recent progress in molecular
biology techniques has led to the identification of five distinct genes of DA-Rs (D1-R-D5-R) and
splice variants. The gene products are classified into the D1-R family (D1-R and D5-R) and D2-R
family (D2-R, D3-R and D4-R) based on their structure and pharmacological features. This re-
view summarizes the structure, localization, function and pharmacology of DA-R subtypes on the
basis of knowledge obtained during the past few years. The genes encoding the D1-R family have
no intron and the D2-R family genes have introns. The distributions of mRNAs encoding these
five DA-R subtypes in the brain were different from their respective receptors. The localization of
DA-R subtypes to particular brain regions and specific pharmacological profiles of DA-R subtypes
allow new insights to be made into the mechanism of action of DA in the control of psychiatric
and motor functions. The availability of detailed information about DA-R subtypes will not only
clarify their roles in the brain, but will probably also lead to the development of new therapeutic
drugs with more specific actions.
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